STERIS Ltd
$
135.11
0.31 (0.23%)
| Volume: | 530,235 | Avg Vol (1m): | 439,169 |
| Market Cap $: | 11.42 Bil | Enterprise Value $: | 12.45 Bil |
| P/E (TTM): | 42.87 | P/B: | 3.71 |
| Earnings Power Value | 16.36 |
| Net Current Asset Value | -10.42 |
| Tangible Book | 1.88 |
| Projected FCF | 52.64 |
| Median P/S Value | 57.48 |
| Graham Number | 11.56 |
| Peter Lynch Value | 23.15 |
| DCF (FCF Based) | 46.54 |
| DCF (Earnings Based) | 33.71 |
1Y (-%)
Manual of Stocks™ Web
Financial Strength : 7/10
GuruFocus Financial Strength Rank measures how strong a company's financial situation is . It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
| Current | vs industry | vs history | |
|---|---|---|---|
| Cash-to-Debt | 0.18 |
Cash-To-Debt ranked
lower than
85.85%
of
205
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 10000, Med: 1.74, Min: 0.01
STE:
0.18
Ranked among companies with meaningful Cash-To-Debt only.
|
Cash-To-Debt range over the past 10 years
Min: 0.04, Med: 0.32, Max: 10000
Current: 0.18
|
| Equity-to-Asset | 0.62 |
Equity-to-Asset ranked
higher than
50.00%
of
196
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 2.26, Med: 0.6, Min: -5.6
STE:
0.62
Ranked among companies with meaningful Equity-to-Asset only.
|
Equity-to-Asset range over the past 10 years
Min: 0.34, Med: 0.58, Max: 0.89
Current: 0.62
|
| Debt-to-Equity | 0.40 |
Debt-to-Equity ranked
lower than
61.27%
of
142
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 3.57, Med: 0.37, Min: 0.01
STE:
0.4
Ranked among companies with meaningful Debt-to-Equity only.
|
Debt-to-Equity range over the past 10 years
Min: 0, Med: 0.34, Max: 0.76
Current: 0.4
|
| Debt-to-EBITDA | 2.06 |
Debt-to-EBITDA ranked
lower than
57.80%
of
109
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 66.68, Med: 1.88, Min: 0.02
STE:
2.06
Ranked among companies with meaningful Debt-to-EBITDA only.
|
Debt-to-EBITDA range over the past 10 years
Min: 0.73, Med: 1.66, Max: 4.38
Current: 2.06
|
| Interest Coverage | 8.61 |
Interest Coverage ranked
lower than
78.83%
of
137
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 21607070, Med: 63.92, Min: 0.47
STE:
8.61
Ranked among companies with meaningful Interest Coverage only.
|
Interest Coverage range over the past 10 years
Min: 4.97, Med: 11.77, Max: 18.48
Current: 8.61
|
| Piotroski F-Score | 7 |
0
1
2
3
4
5
6
7
8
9
| |
| Altman Z-Score | 4.91 |
DISTRESS
GREY
SAFE
| |
| Beneish M-Score | -2.58 |
Not Manipulator
Manipulator
| |
| WACC vs ROIC % |
ROIC 7.82%
WACC 5.72%
| ||
Profitability & Growth : 8/10
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
| Current | vs industry | vs history | |
|---|---|---|---|
| Operating Margin % | 15.13 |
Operating Margin ranked
higher than
73.63%
of
201
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 239.27, Med: 4.41, Min: -219137.5
STE:
15.13
Ranked among companies with meaningful Operating Margin only.
|
Operating Margin range over the past 10 years
Min: 7.16, Med: 13.67, Max: 16.58
Current: 15.13
|
| Net Margin % | 9.85 |
Net Margin ranked
higher than
66.67%
of
201
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 182.67, Med: 4.18, Min: -221450
STE:
9.85
Ranked among companies with meaningful Net Margin only.
|
Net Margin range over the past 10 years
Min: 4.21, Med: 8.25, Max: 11.1
Current: 9.85
|
| ROE % | 8.61 |
ROE ranked
higher than
59.60%
of
198
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 95.67, Med: 5.43, Min: -1452.51
STE:
8.61
Ranked among companies with meaningful ROE only.
|
ROE range over the past 10 years
Min: 3.78, Med: 12.93, Max: 18.11
Current: 8.61
|
| ROA % | 5.29 |
ROA ranked
higher than
60.68%
of
206
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 46.82, Med: 1.85, Min: -307.58
STE:
5.29
Ranked among companies with meaningful ROA only.
|
ROA range over the past 10 years
Min: 2.14, Med: 6.94, Max: 10.46
Current: 5.29
|
| ROC (Joel Greenblatt) % | 27.87 |
ROC (Joel Greenblatt) ranked
higher than
71.57%
of
204
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 387.24, Med: 9.63, Min: -114200
STE:
27.87
Ranked among companies with meaningful ROC (Joel Greenblatt) only.
|
ROC (Joel Greenblatt) range over the past 10 years
Min: 16.35, Med: 30.4, Max: 38.9
Current: 27.87
|
| 3-Year Total Revenue Growth Rate | 12.30 |
3-Year Revenue Growth Rate ranked
lower than
51.76%
of
170
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 1424.9, Med: 4.1, Min: -100
STE:
-0.3
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
|
3-Year Revenue Growth Rate range over the past 10 years
Min: -30.9, Med: 7.8, Max: 189
Current: -0.3
|
| 3-Year Total EBITDA Growth Rate | 22.30 |
3-Year EBITDA Growth Rate ranked
lower than
70.97%
of
155
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 426.6, Med: 10, Min: -759
STE:
8.6
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
|
3-Year EBITDA Growth Rate range over the past 10 years
Min: -26, Med: 7.5, Max: 522
Current: 8.6
|
| 3-Year EPS w/o NRI Growth Rate | 14.60 |
3-Year EPS w/o NRI Growth Rate ranked
lower than
86.45%
of
155
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 253, Med: 12.9, Min: -782.7
STE:
14.6
Ranked among companies with meaningful 3-Year EPS w/o NRI Growth Rate only.
|
3-Year EPS w/o NRI Growth Rate range over the past 10 years
Min: 0, Med: 0.3, Max: 293.6
Current: 14.6
|
» STE's 30-Y Financials
Financials (Next Earnings Date: 2019-08-08)
Guru Trades Click for details
Guru Trades in
SEC Filings
Gurus Latest Trades with NYSE:STE
» Interactive Chart
Peter Lynch Chart
Business Description
| Industry | Medical Instruments & Equipment » Medical Instruments & Supplies   NAICS : 339113   SIC : 3842 |
| Compare | NAS:XRAY NYSE:VAR NYSE:TFX NYSE:WST XSWX:SOONE XSWX:STMN NAS:HOLX XTER:AFX NYSE:COO OCSE:DEMANT NYSE:RMD NAS:MASI TSE:7733 NYSE:HRC TSE:7747 NZSE:FPH NAS:ICUI NYSE:HAE OSTO:EKTA B NAS:NVCR |
| Traded in other countries | 2TG.Germany |
| Address | Rutherford House, Stephensons Way Chaddesden, Derby, GBR, DE21 6LY |
| STERIS PLC operates in four segments: healthcare products, healthcare specialty services, life sciences, and applied sterilization technologies. The healthcare products segment generates the majority of revenue and offers infection prevention equipment and consumables for healthcare providers. The healthcare specialty services segment provides services such as hospital sterilization, instrument repairs, and linen management. The life sciences segment provides equipment, consumables, and maintenance services to pharmaceutical manufacturers and research facilities. The applied sterilization technologies segment provides sterilization and laboratory services to medical device and pharmaceutical manufacturers. Steris generates the majority of its revenue in the United States. | |
Ratios
| Current | vs industry | vs history | |
|---|---|---|---|
| PE Ratio (TTM) | 42.87 |
PE Ratio ranked
lower than
53.60%
of
125
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 1012.86, Med: 31.7, Min: 0.65
STE:
42.87
Ranked among companies with meaningful PE Ratio only.
|
PE Ratio range over the past 10 years
Min: 11.08, Med: 28, Max: 60.81
Current: 42.87
|
| Forward PE Ratio | 25.45 |
Forward P/E ranked
higher than
70.00%
of
40
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 80, Med: 26.32, Min: 12.3
STE:
25.45
Ranked among companies with meaningful Forward P/E only.
| N/A |
| PE Ratio without NRI | 42.87 |
PE without NRI ranked
lower than
52.03%
of
123
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 1012.86, Med: 9999, Min: 0.65
STE:
42.87
Ranked among companies with meaningful PE without NRI only.
|
PE without NRI range over the past 10 years
Min: 11.08, Med: 28, Max: 60.81
Current: 42.87
|
| Price-to-Owner-Earnings | 33.47 |
Price-to-Owner-Earnings ranked
higher than
51.81%
of
83
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 631.1, Med: 30.92, Min: 1.32
STE:
33.47
Ranked among companies with meaningful Price-to-Owner-Earnings only.
|
Price-to-Owner-Earnings range over the past 10 years
Min: 8.67, Med: 21.13, Max: 60.59
Current: 33.47
|
| PB Ratio | 3.71 |
PB Ratio ranked
higher than
60.10%
of
193
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 53.91, Med: 3.45, Min: 0.13
STE:
3.71
Ranked among companies with meaningful PB Ratio only.
|
PB Ratio range over the past 10 years
Min: 1.68, Med: 2.51, Max: 4.19
Current: 3.71
|
| PS Ratio | 4.23 |
PS Ratio ranked
higher than
52.60%
of
192
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 720.69, Med: 3.48, Min: 0.08
STE:
4.23
Ranked among companies with meaningful PS Ratio only.
|
PS Ratio range over the past 10 years
Min: 0.94, Med: 1.8, Max: 4.31
Current: 4.23
|
| Price-to-Free-Cash-Flow | 35.53 |
Price-to-Free-Cash-Flow ranked
higher than
50.00%
of
74
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 794.44, Med: 28.61, Min: 0.95
STE:
35.53
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
|
Price-to-Free-Cash-Flow range over the past 10 years
Min: 8.74, Med: 25.05, Max: 113.68
Current: 35.53
|
| Price-to-Operating-Cash-Flow | 23.56 |
Price-to-Operating-Cash-Flow ranked
higher than
63.83%
of
94
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 807.55, Med: 21.15, Min: 0.86
STE:
23.56
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
|
Price-to-Operating-Cash-Flow range over the past 10 years
Min: 7.09, Med: 14.38, Max: 25.66
Current: 23.56
|
| EV-to-EBIT | 32.26 |
EV-to-EBIT ranked
lower than
59.50%
of
121
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 126.36, Med: 23.93, Min: 0.21
STE:
32.26
Ranked among companies with meaningful EV-to-EBIT only.
|
EV-to-EBIT range over the past 10 years
Min: 7.1, Med: 18.2, Max: 40.3
Current: 32.26
|
| EV-to-EBITDA | 20.52 |
EV-to-EBITDA ranked
higher than
60.87%
of
138
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 614.98, Med: 19.49, Min: 0.2
STE:
20.52
Ranked among companies with meaningful EV-to-EBITDA only.
|
EV-to-EBITDA range over the past 10 years
Min: 5.4, Med: 12.7, Max: 24.9
Current: 20.52
|
| EV-to-Revenue | 4.56 |
EV-to-Revenue ranked
higher than
50.25%
of
199
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 4881, Med: 3.57, Min: 0.12
STE:
4.56
Ranked among companies with meaningful EV-to-Revenue only.
|
EV-to-Revenue range over the past 10 years
Min: 1, Med: 2, Max: 4.6
Current: 4.56
|
| PEG Ratio | 11.57 |
PEG Ratio ranked
lower than
100.00%
of
69
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 112.54, Med: 2.7, Min: 0.05
STE:
11.57
Ranked among companies with meaningful PEG Ratio only.
|
PEG Ratio range over the past 10 years
Min: 1.36, Med: 2.67, Max: 231.65
Current: 11.57
|
| Shiller PE Ratio | 59.30 |
Shiller PE Ratio ranked
higher than
59.26%
of
54
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 600, Med: 50.97, Min: 0.42
STE:
59.3
Ranked among companies with meaningful Shiller PE Ratio only.
|
Shiller PE Ratio range over the past 10 years
Min: 17.91, Med: 28.43, Max: 60.21
Current: 59.3
|
| Current Ratio | 2.56 |
Current Ratio ranked
higher than
55.50%
of
200
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 30.7, Med: 2.57, Min: 0.1
STE:
2.56
Ranked among companies with meaningful Current Ratio only.
|
Current Ratio range over the past 10 years
Min: 1.44, Med: 2.5, Max: 8.51
Current: 2.56
|
| Quick Ratio | 1.99 |
Quick Ratio ranked
higher than
61.19%
of
201
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 30.69, Med: 1.87, Min: -1.52
STE:
1.99
Ranked among companies with meaningful Quick Ratio only.
|
Quick Ratio range over the past 10 years
Min: 0.92, Med: 1.9, Max: 7.97
Current: 1.99
|
| Days Inventory | 51.14 |
Days Inventory ranked
higher than
88.32%
of
197
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 876.25, Med: 124.35, Min: 0.86
STE:
51.14
Ranked among companies with meaningful Days Inventory only.
|
Days Inventory range over the past 10 years
Min: 44.92, Med: 59.42, Max: 70.76
Current: 51.14
|
| Days Sales Outstanding | 68.17 |
Days Sales Outstanding ranked
lower than
55.15%
of
165
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 655.77, Med: 61.97, Min: 1
STE:
68.17
Ranked among companies with meaningful Days Sales Outstanding only.
|
Days Sales Outstanding range over the past 10 years
Min: 62.38, Med: 69.06, Max: 82.3
Current: 68.17
|
| Days Payable | 31.28 |
Days Payable ranked
lower than
76.82%
of
151
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 713.41, Med: 54.66, Min: 2
STE:
31.28
Ranked among companies with meaningful Days Payable only.
|
Days Payable range over the past 10 years
Min: 30.7, Med: 33.62, Max: 43.62
Current: 31.28
|
Dividend & Buy Back
| Current | vs industry | vs history | |
|---|---|---|---|
| Dividend Yield % | 0.98 |
Trailing Dividend Yield ranked
higher than
61.59%
of
164
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 106.45, Med: 1.16, Min: 0.01
STE:
0.98
Ranked among companies with meaningful Trailing Dividend Yield only.
|
Trailing Dividend Yield range over the past 10 years
Min: 0.63, Med: 1.42, Max: 2.34
Current: 0.98
|
| Dividend Payout Ratio | 0.41 |
Dividend Payout Ratio ranked
lower than
51.00%
of
100
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 10, Med: 0.31, Min: 0.01
STE:
0.41
Ranked among companies with meaningful Dividend Payout Ratio only.
|
Dividend Payout Ratio range over the past 10 years
Min: 0.16, Med: 0.37, Max: 0.85
Current: 0.41
|
| 3-Year Dividend Growth Rate (Per Share) | 10.40 |
3-Year Dividend Growth Rate ranked
higher than
56.45%
of
62
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 72.6, Med: 8.9, Min: -100
STE:
10.4
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
|
3-Year Dividend Growth Rate range over the past 10 years
Min: 0, Med: 0, Max: 34.7
Current: 10.4
|
| Forward Dividend Yield % | 1.01 |
Forward Dividend Yield ranked
higher than
51.55%
of
161
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 10.53, Med: 1.3, Min: 0.02
STE:
1.01
Ranked among companies with meaningful Forward Dividend Yield only.
| N/A |
| Yield-on-Cost (5-Year) % | 1.59 |
Yield-on-Cost (5y) ranked
higher than
68.42%
of
209
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 106.45, Med: 1.44, Min: 0.01
STE:
1.59
Ranked among companies with meaningful Yield-on-Cost (5y) only.
|
Yield-on-Cost (5y) range over the past 10 years
Min: 1.02, Med: 2.31, Max: 3.8
Current: 1.59
|
| 3-Year Share Buyback Rate | -12.40 |
3-Year Share Buyback Rate ranked
lower than
72.73%
of
143
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 9.1, Med: -5, Min: -273.3
STE:
-12.4
Ranked among companies with meaningful 3-Year Share Buyback Rate only.
|
3-Year Share Buyback Rate range over the past 10 years
Min: -37.6, Med: -0.6, Max: 5.2
Current: -12.4
|
Valuation & Return
| Current | vs industry | vs history | |
|---|---|---|---|
| Price-to-Tangible-Book | 71.87 |
Price-to-Tangible-Book ranked
lower than
99.40%
of
167
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 3100, Med: 4.77, Min: 0.22
STE:
71.87
Ranked among companies with meaningful Price-to-Tangible-Book only.
|
Price-to-Tangible-Book range over the past 10 years
Min: 2.69, Med: 4.88, Max: 1749.4
Current: 71.87
|
| Price-to-Projected-FCF | 2.57 |
Price-to-Intrinsic-Value-Projected-FCF ranked
higher than
60.00%
of
75
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 161.65, Med: 2.41, Min: 0.16
STE:
2.57
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
|
Price-to-Intrinsic-Value-Projected-FCF range over the past 10 years
Min: 0.81, Med: 1.66, Max: 58.73
Current: 2.57
|
| Price-to-DCF (Earnings Based) | 4.01 |
Price-to-Intrinsic-Value-DCF (Earnings Based) ranked
lower than
100.00%
of
23
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 94.53, Med: 2.2, Min: 1.04
STE:
4.01
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
|
Price-to-Intrinsic-Value-DCF (Earnings Based) range over the past 10 years
Min: 0.44, Med: 1.69, Max: 3.9
Current: 4.01
|
| Price-to-Median-PS-Value | 2.35 |
Price-to-Median-PS-Value ranked
lower than
82.50%
of
160
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 4.9, Med: 1.13, Min: 0.01
STE:
2.35
Ranked among companies with meaningful Price-to-Median-PS-Value only.
|
Price-to-Median-PS-Value range over the past 10 years
Min: 0.36, Med: 0.91, Max: 3.36
Current: 2.35
|
| Price-to-Peter-Lynch-Fair-Value | 5.84 |
Price-to-Peter-Lynch-Fair-Value ranked
lower than
100.00%
of
45
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 111.95, Med: 2.46, Min: 0.26
STE:
5.84
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
|
Price-to-Peter-Lynch-Fair-Value range over the past 10 years
Min: 0.83, Med: 2.08, Max: 41.83
Current: 5.84
|
| Price-to-Graham-Number | 11.69 |
Price-to-Graham-Number ranked
lower than
100.00%
of
94
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 53.19, Med: 2.77, Min: 0.13
STE:
11.69
Ranked among companies with meaningful Price-to-Graham-Number only.
|
Price-to-Graham-Number range over the past 10 years
Min: 1.19, Med: 2.59, Max: 48.87
Current: 11.69
|
| Earnings Yield (Joel Greenblatt) % | 3.11 |
Earnings Yield (Greenblatt) ranked
higher than
65.22%
of
207
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 476.19, Med: 2.4, Min: -3333.33
STE:
3.11
Ranked among companies with meaningful Earnings Yield (Greenblatt) only.
|
Earnings Yield (Greenblatt) range over the past 10 years
Min: 2.5, Med: 5.5, Max: 14
Current: 3.11
|
| Forward Rate of Return (Yacktman) % | 9.48 |
Forward Rate of Return ranked
lower than
68.32%
of
101
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 28.23, Med: 8.66, Min: -123.3
STE:
9.48
Ranked among companies with meaningful Forward Rate of Return only.
|
Forward Rate of Return range over the past 10 years
Min: -1.7, Med: 10.1, Max: 18.4
Current: 9.48
|
More Statistics
| Revenue (TTM) (Mil) $ | 2,729.93 |
| EPS (TTM) $ | 3.15 |
| Beta | 0.82 |
| Volatility % | 21.07 |
| 52-Week Range $ | 99.14 - 137.6 |
| Shares Outstanding (Mil) | 84.51 |
Analyst Estimate
Piotroski F-Score Details
| Piotroski F-Score | 7 |
| Positive ROA | Y |
| Positive CFROA | Y |
| Higher ROA yoy | Y |
| CFROA > ROA | Y |
| Lower Leverage yoy | Y |
| Higher Current Ratio yoy | N |
| Less Shares Outstanding yoy | Y |
| Higher Gross Margin yoy | N |
| Higher Asset Turnover yoy | Y |